Testing effectiveness (Phase 2)Looking for participantsNCT07257653
What this trial is testing
The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer
Who this might be right for
Colorectal NeoplasmsRASBRAF+2 more
Zhejiang University 70